Group B Streptococcus
Meridian Bioscience Awarded Agreement with GPO Premier for Molecular Diagnostics
Meridian Bioscience Inc. announced it has signed a new group purchasing agreement with Premier healthcare alliance to offer Illumigene C. difficile and Illumigene Group B Streptococcus to its members at specially negotiated pricing. Premier is a group purchasing organization (GPO) that serves upward of 2500 U.S. hospitals and 81,000-plus other healthcare sites. This new agreement allows facilities doing business with Premier to implement rapid, sensitive molecular...